Fit to burst: How cancer-exploding viruses are changing the game
You awake in the middle of the night from a nightmare.
Feb 10, 2020
1
976
You awake in the middle of the night from a nightmare.
Feb 10, 2020
1
976
A strain of the common cold virus has been found to potentially target, infect and destroy cancer cells in patients with bladder cancer, a new study in the medical journal Clinical Cancer Research reports. No trace of the ...
Jul 5, 2019
3
10
Restricting the ability of cancer cells to metabolise sugar could make oncolytic viruses more effective at attacking them, suggests a study published today in the journal Cancer Research.
Nov 28, 2018
0
1
Novel Technique Can Potentially Improve Success of Ovarian Cancer Treatment, Study Reveals
Oct 30, 2018
0
18
Researchers at the University of Helsinki have reported PeptiENV, a cancer vaccine platform that can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use. With the help of this ...
Oct 5, 2018
0
2
Scientists have learned how to observe the processes of oncolytic viruses in cancer cells in real time. For the first time ever, a group of scientists from NUST MISIS and the University of Calgary (Canada) has applied intravital ...
Sep 10, 2018
0
6
Mayo Clinic researchers have discovered that a molecular communication pathway—thought to be defective in cancer—is a key player in determining the effectiveness of measles virus oncolytic cancer treatment in ovarian ...
May 16, 2018
0
6
A new UC San Francisco study has shown that a cancer-killing ("oncolytic") virus currently in clinical trials may function as a cancer vaccine—in addition to killing some cancer cells directly, the virus alerts the immune ...
Feb 13, 2018
1
1267
Immunotherapy, which helps the body's immune system attack cancer, has revolutionized treatment for cancers such as melanoma and leukemia. However, many other kinds of cancer remain resistant. A new study led by researchers ...
Jan 3, 2018
0
614
Virotherapy capable of destroying tumor cells and activating anti-tumor immune reactions, and the use of engineered hematopoietic stem cells (HSCs) to deliver replacement genes that have the potential to cure blood diseases ...
Oct 18, 2017
0
3